2024-01-26 10:27:28 ET
Summary
- Veeva Systems is a highly attractive SaaS stock with a large moat and a recession-resistant customer base.
- The company has announced some nice wins recently, including a partnership with Fortrea and Advarra to streamline the clinical trial experience.
- Veeva's R&D Solutions business is a strong growth driver, and commitments from Bayer and GSK to transition to its CRM Vault platform help mitigate some risks.
...
Read the full article on Seeking Alpha
For further details see:
Veeva Systems: Long-Term Story Intact Despite Professional Service Weakness